8/3/26 +6.1%

Martin Shkreli provides a live, unfiltered tutorial on day trading, market making, and biotech analysis. He guides an associate through tracking P&L, managing order books, and executing trades while simultaneously analyzing real-time market movements in stocks like Intel, NVIDIA, and Palantir. Shkreli emphasizes the importance of rigid risk management, sizing over timing, and deep research into clinical trial data for biotech investments. He dismisses conventional technical analysis as unreliable, advocating instead for a disciplined, system-based approach to trading. The session culminates in a real-time reaction to Palantir’s earnings report, where Shkreli evaluates Total Contract Value (TCV) metrics to justify his short position. Throughout the stream, he maintains a combative, instructional tone, blending professional financial insights with personal anecdotes and direct mentorship.